Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells

European Journal of Cancer Part A

Volumn 33, Issue 4, 1997, Pages 669-675

  Marverti, G ^a   Andrews, P A ^b   Piccinini, G ^a   Ghiaroni, S ^a   Barbieri, D ^a   Moruzzi, M S ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

cell membrane permeability; cisplatin; drug resistance; drug transport; polyamines

Indexed keywords

CISPLATIN; MANNITOL; POLYAMINE; SPERMINE;

ARTICLE; CANCER RESISTANCE; CANCER SURVIVAL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG MIXTURE; DRUG POTENTIATION; DRUG TRANSPORT; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL MEMBRANE PERMEABILITY; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; HUMANS; MANNITOL; OVARIAN NEOPLASMS; POLYAMINES; SPERMINE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0031006286     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00507-2     Document Type: Article

References (31)

1. Andrews PA. Mechanisms of acquired resistance to cisplatin. In Goldstein LJ, Ozols RF, eds. Amicancer Drug Resistance: Advances in Molecular and Clinical Research. Boston, MA, Kluwer Academic, 1994, 217-246.
2. Andrews PA, Jones JA, Varki NM, Howell SB. Rapid emergence of acquired cis-diamminedichloroplatinum (II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun 1990, 2, 93-100.
3. Andrews PA, Mann SC, Velury S, Howell SB. Cisplatin uptake mediated cisplatin-resistance in human ovarian carcinoma cells. In Nicolini M, ed. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Padua, Italy, Martinus Nijhoff Publishing, 1987, 248-254.
4. Andrews PA, Mann SC, Huynh HH, Albright KD. Role of Na + , K + adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum (II) in human ovarian carcinoma cells. Cancer Res 1991, 51, 3677-3681.
5. Mann SC, Andrews PA, Howell SB. Short-term cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Chemother Pharmacol 1990, 25, 236-240.
6. Gately DP, Howell SB. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993, 67, 1171-1176.
7. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986, 234, 249-262.
8. Bachrach U, Abzug S, Bekierkunst A. Cytotoxic effect of oxidized spermine on Ehrlich ascites cells. Biochim Biophys Acta 1967, 134, 174-181.
9. Allen JC, Smith CJ, Hussain JI, Thomas JM, Gaugas JM. Inhibition of lymphocyte proliferation by polyamines requires ruminant-plasma polyamine oxidase. Eur J Biochem 1979, 102, 153-158.
10. Shore PA, Cohn VH Jr. Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase. Biochem Pharmacol 1960, 5, 91-95.
11. He Y, Kashiwagi K, Fukuchi J, Terao K, Shirahata A, Igarashi K. Correlation between the inhibition of cell growth by accumulated polyamines and the decrease of magnesium and ATP. Eur J Biochem 1993, 217, 89-96.
12. Brunton VG, Grant MH, Wallace HM. Mechanisms of spermine toxicity in baby-hamster kidney (BHK) cells. Biochem J 1991, 280, 193-198.
13. Schuber F. Influence of polyamines on membrane functions. Biochem J 1989, 260, 1-10.
14. Zinkewich-Péotti K, Andrews PA. Loss of cis-diamminedichloroplatinum (II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance. Cancer Res 1992, 52, 1902-1906.
15. Mann SC, Andrews PA, Howell SB. Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 1991, 48, 866-872.
16. Chou TC, Talalay P. Quantitative analysis of dose - effect relationships: the combined effects of multiple drugs or enzyme inhibitors. In Weber G, ed. Advances in Enzyme Regulation. New York, Pergamon Press, 1984, 27-55.
17. Andrews PA, Velury S, Mann SC, Howell SB. cis-Diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 1988, 48, 68-73.
18. Dawson DC. Na and C1 transport across the isolated turtle colon: parallel pathway for transmural ion movement. J Membr Biol 1977, 37, 213-233.
19. Madara JL, Berenberg D, Carlson S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 1986, 102, 2125-2136.
20. Seiler N, Knödgen B, Eisenbeiss F. Determination of di-and polyamines by high-performance liquid chromatographic separation of their 5-dimethylaminonaphthalene-1-sulfonyl derivatives. J Chromatogr 1978, 145, 29-39.
21. Bazzani C, Genedani S, Tagliavini S, Piccinini G, Bertolini A. Treatment with polyamine synthesis inhibitors reduces the positive ionotropic effect of ouabain, noradrenaline and calcium. Pharm Res Commun 1988, 20, 23-35.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265-275.
23. Marverti G, Andrews PA. Stimulation of cis-diamminedichloroplatinum (II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells. Clin Cancer Res, 1996, 2, 991-999.
24. Brunton VG, Grant MH, Wallace HM. Spermine toxicity and glutathione depletion in BHK-21/C13 cells. Biochem Pharmacol 1990, 40, 1893-1900.
25. Melvin MAL, Keir HM. Excretion of polyamines from mammalian cells in culture. In Polyamines in Biomedical Research. New York, Wiley, 1980, 363-381.
26. Oredsson SM, Deen DF, Marton LJ. Decreased cytotoxicity of cis-diamminedichloroplatinum (II) by α-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro. Cancer Res 1982, 42, 1296-1299.
27. Allen ED, Natale RB. Effect of α-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminedichloroplatinum (II) and vinblastine sulfate on the growth of P3J cells in vitro. Cancer Res 1986, 46, 3550-3555.
28. Roizin-Towle L. Studies with cis-diamminedichloroplatinum (II) and exogenous polyamines using mammalian cells in culture. Br J Cancer 1981, 43, 378-383.
29. Schuber F, Hong K, Düzgünes N, Papahadjopoulos D. Polyamines as modulators of membrane fusion: aggregation and fusion of liposomes. Biochemistry 1983, 22, 6134-6139.
30. Mann SC, Andrews PA, Howell SB. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Anticancer Res 1988, 8, 1211-1215.
31. Andrews PA, Albright KD. Mitochondrial defects in cis-diamminedichloroplatinum (II)-resistant human ovarian carcinoma cells. Cancer Res 1992, 52, 1895-1901.